Patent · US Active

Identification of a conserved inner core oligosaccharide of Moraxella catarrhalis lipopolysaccharide as a vaccine antigen

US8697092B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Inventors

Andrew Cox · Ottawa, CA
James Clare Richards · Ottawa, CA

Key dates

Filing date	Sep 4, 2009
Grant date	Apr 15, 2014
Priority date	—
Expiry date	Sep 4, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6087
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are disclosed herein antigenic structures useful in producing vaccines against and compounds helpful in combating diseases caused by the bacterium Moraxella catarrhalis. Disclosed are specific structures of the carbohydrate molecules derived from genetically engineered strains of Moraxella catarrhalis, which when presented appropriately to the immune system will facilitate a functional immune response to the target core oligosaccharide region.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.